-->

David MD - Alimera Sciences Chief Specialist

Insider

David MD is Chief Specialist of Alimera Sciences
Phone678 990 5740
Webhttps://alimerasciences.com

Alimera Sciences Management Efficiency

Alimera Sciences' management efficiency ratios could be used to measure how well Alimera Sciences manages its routine affairs as well as how well it operates its assets and liabilities.
Alimera Sciences currently holds 67.4 M in liabilities. Alimera Sciences has a current ratio of 1.27, suggesting that it is in a questionable position to pay out its financial obligations when due. Note, when we think about Alimera Sciences' use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Matthew BryantPaysafe
36
James MurrenPaysafe
58
Lawrence JacksonServiceNow
39
Chi LeePaysafe
50
Ryan PolleyMarchex
52
Fehmi ZekoEntravision Communications
61
Peter RutlandPaysafe
41
Eli NaglerPaysafe
34
Bruce LowthersPaysafe
59
Mark BrookerPaysafe
N/A
Kevin HavertyServiceNow
54
Cheryl TrbulaAsure Software
N/A
John RoswechMarchex
55
Elliott WisemanPaysafe
51
Christopher BediServiceNow
48
Hilary StewartJonesPaysafe
58
Chris MunozEntravision Communications
N/A
Richard SwalesPaysafe
52
Paul SmithServiceNow
53
Joseph QuinlanServiceNow
N/A
Edward MelendezEntravision Communications
N/A
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia. Alimera Sciences operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 145 people. Alimera Sciences (ALIM) is traded on NASDAQ Exchange in USA and employs 154 people.

Management Performance

Alimera Sciences Leadership Team

Elected by the shareholders, the Alimera Sciences' board of directors comprises two types of representatives: Alimera Sciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Alimera. The board's role is to monitor Alimera Sciences' management team and ensure that shareholders' interests are well served. Alimera Sciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Alimera Sciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
Christopher Visick, General VP
Philip Ashman, Sr. VP and European Managing Director
Jason Werner, Chief Officer
David Holland, Co-Founder and Sr. VP of Sales and Marketing
Todd Wood, President Operations
Richard Eiswirth, Pres and CFO
Charles Myers, NonEx Consultant
David MD, Chief Specialist
Elliot CPA, CFO Treasurer

Alimera Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Alimera Sciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Consideration for investing in Alimera Stock

If you are still planning to invest in Alimera Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alimera Sciences' history and understand the potential risks before investing.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments